Fernanda P Pons-Faudoa - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Fernanda P Pons-Faudoa

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Science Translational Medicine|June 28, 2023

Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primatesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.

AIDS Research and Human Retroviruses|April 29, 2021

Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development MeetingJoseph W Romano, Marc M Baum, Zach R Demkovich, et al.

Advanced Therapeutics|May 17, 2021

Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primatesFernanda P Pons-Faudoa, Antons Sizovs, Kathryn A Shelton, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Science Translational Medicine|June 28, 2023

Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primatesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.

AIDS Research and Human Retroviruses|April 29, 2021

Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development MeetingJoseph W Romano, Marc M Baum, Zach R Demkovich, et al.

Advanced Therapeutics|May 17, 2021

Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primatesFernanda P Pons-Faudoa, Antons Sizovs, Kathryn A Shelton, et al.

Pageof 2